UBS Group’s Hoth Therapeutics HOTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$49.4K Sell
42,240
-16,518
-28% -$19.3K ﹤0.01% 6499
2025
Q1
$58.8K Buy
58,758
+27,765
+90% +$27.8K ﹤0.01% 6171
2024
Q4
$23.2K Sell
30,993
-25,471
-45% -$19.1K ﹤0.01% 6553
2024
Q3
$49.7K Buy
56,464
+13,109
+30% +$11.5K ﹤0.01% 5628
2024
Q2
$39.4K Buy
43,355
+41,205
+1,917% +$37.5K ﹤0.01% 5723
2024
Q1
$3.27K Sell
2,150
-6,297
-75% -$9.57K ﹤0.01% 6579
2023
Q4
$12.2K Buy
8,447
+4,297
+104% +$6.19K ﹤0.01% 6158
2023
Q3
$6.31K Sell
4,150
-144
-3% -$219 ﹤0.01% 6170
2023
Q2
$12.9K Sell
4,294
-4,534
-51% -$13.6K ﹤0.01% 5983
2023
Q1
$18.2K Buy
8,828
+4,849
+122% +$9.99K ﹤0.01% 6057
2022
Q4
$31K Buy
3,979
+3,817
+2,356% +$29.8K ﹤0.01% 6042
2022
Q3
$1K Sell
162
-74
-31% -$457 ﹤0.01% 8855
2022
Q2
$2K Sell
236
-182
-44% -$1.54K ﹤0.01% 8515
2022
Q1
$7K Buy
+418
New +$7K ﹤0.01% 7762
2021
Q4
Sell
-39
Closed -$1K 9221
2021
Q3
$1K Buy
+39
New +$1K ﹤0.01% 8030
2021
Q2
Sell
-216
Closed -$11K 8385
2021
Q1
$11K Buy
216
+30
+16% +$1.53K ﹤0.01% 6831
2020
Q4
$11K Buy
+186
New +$11K ﹤0.01% 6383
2020
Q3
Sell
-24
Closed -$2K 7217
2020
Q2
$2K Buy
24
+3
+14% +$250 ﹤0.01% 6769
2020
Q1
$2K Sell
21
-61
-74% -$5.81K ﹤0.01% 6690
2019
Q4
$13K Buy
82
+70
+583% +$11.1K ﹤0.01% 6068
2019
Q3
$1K Sell
12
-79
-87% -$6.58K ﹤0.01% 6863
2019
Q2
$13K Buy
91
+83
+1,038% +$11.9K ﹤0.01% 6015
2019
Q1
$1K Buy
+8
New +$1K ﹤0.01% 6704